1. The 2023 Deregulation Paradox
When IRDAI introduced the flexible EoM regime in April 2023, the objective was operational autonomy: allowing boards to allocate expenses dynamically between tech, marketing, and distribution.
Finsamudra Desk
In a rare public endorsement of regulatory intervention, Star Health and Allied Insurance Company Limited, India’s largest standalone health insurer (SAHI), has backed the Insurance Regulatory and Development Authority of India’s (IRDAI) proposal to reintroduce statutory ceilings on intermediary commissions.
-1200x675.jpg&w=3840&q=75)
When IRDAI introduced the flexible EoM regime in April 2023, the objective was operational autonomy: allowing boards to allocate expenses dynamically between tech, marketing, and distribution.
Instead, it triggered a classic prisoner's dilemma. Large private insurers and specialized health players began offering steep, front-loaded commissions and rewards to bancassurance tie-ups, corporate aggregators, and top brokerages to capture exclusive distributor shelf space.
As acquisition costs spiked, underwriting margins compressed. To protect solvency margins, insurers steadily raised base retail premiums, creating customer pushback and stalling policy persistency.
Under the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025, the IRDAI released its consultation paper titled “Recalibrating Economics of Insurance Distribution” on September 23, 2026.
The paper outlines four foundational pillars:
Star Health’s backing of the regulator is closely tied to its product and distribution strategy. With over 700,000 agents, Star Health possesses India’s largest proprietary health distribution network.
While diversified general insurers rely heavily on bank partnerships, Star Health’s agency-led model benefits when commission wars in the corporate broker and bancassurance spaces are reined in.
Simultaneously, the launch of Young Star NEO (targeted at individuals aged 18 to 40) introduces a pricing architecture that directly reflects lower distribution friction:
Such retail underwriting models are only financially viable if acquisition costs remain tightly capped.
While broker associations and bancassurance lobbies have voiced opposition ahead of the IRDAI's final mid-December 2026 exposure draft, Star Health’s public endorsement gives the regulator significant institutional backing. Capping commissions will compress intermediary margins in the near term, but it represents the only viable path to reducing retail premiums, eliminating mis-selling, and driving health insurance penetration beyond India's urban core.
From Finsamudra
If you already source loans, Finsamudra lets you place them with 30+ banks and NBFCs, with eligibility checked with every lender in one go before the file is submitted. Partners are paid on disbursal – free to join, no exclusivity. Become a DSA partner
Finsa · Sponsored
Need more money and already repaying a loan?
A top-up borrows against what you have already cleared — often cheaper than a second personal loan. Compare both free.
Sources
Refer loans to banks and NBFCs? Become a loan DSA partner
Finsamudra Desk
On November 13, 2026, via Press Release 2026-2027/1498 (prid=63971), the Reserve Bank of India (RBI) published the Scheduled Banks’ Statement of Position in India as on October 31, 2026, capturing statutory returns submitted under Section 42(2) of the Reserve Bank of India Act, 1934.
Guides3 min read
Finsamudra Desk
On November 9, 2026, Bengaluru-based artificial intelligence unicorn Sarvam AI announced the appointment of Sashikumar Sreedharan, former Managing Director of Google Cloud India, as President and Chief Business Officer (CBO), alongside his induction onto the company’s Board of Directors.
Guides3 min read
Get the Morning Brief
The same daily intelligence 41,000+ CXOs, DSAs and finance professionals follow on LinkedIn, with the Finsamudra take.